SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-15-002253
Filing Date
2015-08-19
Accepted
2015-08-19 16:02:47
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q biostarpharma10q063015.htm 10-Q 1219824
2 EX-31.1 ex31-1.htm EX-31.1 16260
3 EX-31.2 ex31-2.htm EX-31.2 15570
4 EX-32.1 ex32-1.htm EX-32.1 6977
5 EX-32.2 ex32-2.htm EX-32.2 5930
  Complete submission text file 0001185185-15-002253.txt   5960650

Data Files

Seq Description Document Type Size
6 EX-101.INS bspm-20150630.xml EX-101.INS 1466833
7 EX-101.SCH bspm-20150630.xsd EX-101.SCH 52901
8 EX-101.CAL bspm-20150630_cal.xml EX-101.CAL 43140
9 EX-101.DEF bspm-20150630_def.xml EX-101.DEF 252310
10 EX-101.LAB bspm-20150630_lab.xml EX-101.LAB 316147
11 EX-101.PRE bspm-20150630_pre.xml EX-101.PRE 254230
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 151064048
SIC: 2834 Pharmaceutical Preparations